Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis

Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis

Background and Aims: Mucosal lesions refractory to biological treatments represent unmet needs in patients with inflammatory bowel disease (IBD) that require new treatment modalities. We developed and characterized a new endoscopic drug-eluting hydrogel (CoverGel) with proven efficacy in acute and c...

Full description

Bibliographic Details
Main Authors: Ignacio Bon, Mary Cano-Sarabia, Napoleon de la Ossa, Ramon Bartolí, Vicente Lorenzo-Zúñiga
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Medicine
Subjects:
drug-eluting
experimental colitis
endoscopic shielding technique
hydrogel
endoscopy
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00415/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00415/full

Similar Items